Research programme: protein kinase inhibitors - Genosco

Drug Profile

Research programme: protein kinase inhibitors - Genosco

Alternative Names: EGFR inhibitors - Genosco; Epidermal growth factor receptor inhibitors - Genosco; FLT3 inhibitor - Genosco; FMS-like tyrosine kinase-3 inhibitors - Genosco; G-801; GNS-1480; LRRK2 inhibitors - Genosco; Spleen tyrosine kinase inhibitors - Genosco; SYK inhibitors - Genosco

Latest Information Update: 02 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Genosco
  • Developer Genosco; Yuhan
  • Class Small molecules
  • Mechanism of Action Epidermal growth factor receptor antagonists; Fibroblast growth factor receptor antagonists; Fms-like tyrosine kinase 3 inhibitors; LRRK2 protein inhibitors; Syk kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Acute myeloid leukaemia; Non-small cell lung cancer
  • Research Diffuse large B cell lymphoma; Hepatocellular carcinoma; Parkinson's disease; Peripheral T-cell lymphoma

Most Recent Events

  • 02 Sep 2016 Early research in Diffuse large B cell lymphoma in USA (unspecified route) before September 2016
  • 02 Sep 2016 Early research in Hepatocellular carcinoma in USA (unspecified route) before September 2016
  • 02 Sep 2016 Early research in Parkinson's disease in USA (unspecified route) before September 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top